For Quick Alerts
For Daily Alerts

Suven Life Sciences to incorporate overseas subsidiary

By Religare

Suven Life Sciences Ltd said that it has received an approval to create an overseas subsidiary with an initial investment of USD 25 million for clinical development and commercialization of Suven pipeline and in-licensed molecules.

The board of directors at their meeting held on August 14, 2015 has approved for the same, the company said in a filing to the Bombay Stock Exchange.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.


Meanwhile, shares of the company were trading at Rs 247.15 a piece, down 3.08 per cent from the previous close at 11:19 hours on BSE.

Story first published: Monday, August 17, 2015, 12:30 [IST]
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'


We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more